Indivior Inc.
Records under this name other than the patents Indivior Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Showing 1 to 4 of 4 · Back to Indivior Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,289,425 | Intranasal naloxone compositions and methods of making and using same Formerly held Lapsed on the fee record Ended Mar 22, 2024 · USPTO record | Lapsed on the fee record | Ended Mar 22, 2024 | USPTO record |
| US 9,192,570 | Intranasal naloxone compositions and methods of making and using same Formerly held Lapsed on the fee record Ended Nov 24, 2023 · USPTO record | Lapsed on the fee record | Ended Nov 24, 2023 | USPTO record |
| US 10,149,912 | Dehydrated hydrogel inclusion complex Formerly held Lapsed on the fee record Ended Dec 11, 2022 · USPTO record | Lapsed on the fee record | Ended Dec 11, 2022 | USPTO record |
| US 9,486,531 | Dehydrated hydrogel inclusion complex of a bioactive agent with flowable drug delivery system Formerly held Lapsed on the fee record Ended Nov 8, 2020 · USPTO record | Lapsed on the fee record | Ended Nov 8, 2020 | USPTO record |